Arbaclofen for Autism: Brain Wave Study
Part of Mental health clinical trials.
This study tests a medicine called arbaclofen to see how it affects brain waves in people with autism. It includes a brief double-blind crossover phase followed by a 10-week open-label treatment period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with autism spectrum disorder (ASD).
- You are between 7 and 23 years old.
- You have taken part in the earlier AIMS-2 CT1 study.
- Your current medications for behavior or seizures have been stable for at least 6 weeks, and other therapies for 3 months.
- If you have a history of seizures, you must be seizure-free for 6 months (if on medication) or 3 years (if not on meds).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a “reward system” approach in the brain for adults with autism (and also for adults with food addiction and for healthy volunteers). It may help researchers understand brain and behavior differences and whether this kind of task-based training is safe and useful.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.
This trial tests a new therapy that aims to help the brain grow new connections in children with autism. It uses a non-invasive device, so no surgery or drugs are involved, and it may help improve communication and daily skills.
This study looks at how a brain chemical related to calming signals (“GABA”) may affect how people process sounds in autism. The goal is to understand brain function during hearing tasks, which could help guide future treatments.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
Hear when a new Autism Spectrum Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.